Showing results (41-50 of 66) with videos related to
Sort By:
Pageof 7
Cancers|January 21, 2023
Sphingosine-1-Phosphate Recruits Macrophages and Microglia and Induces a Pro-Tumorigenic Phenotype That Favors Glioma ProgressionLavinia Arseni, Rakesh Sharma, Norman Mack, et al.Leukemia|March 18, 2021
EOMES is essential for antitumor activity of CD8<sup>+</sup> T cells in chronic lymphocytic leukemiaLaura Llaó-Cid, Philipp M Roessner, Vicente Chapaprieta, et al.EMBO Reports|October 26, 2017
Branched-chain ketoacids secreted by glioblastoma cells via MCT1 modulate macrophage phenotypeLidia Santos Silva, Gernot Poschet, Yannic Nonnenmacher, et al.Leukemia|August 21, 2021
Longitudinal analyses of CLL in mice identify leukemia-related clonal changes including a Myc gain predicting poor outcome in patientsSelcen Öztürk, Yashna Paul, Saira Afzal, et al.The Journal of Clinical Investigation|October 3, 2018
CD84 regulates PD-1/PD-L1 expression and function in chronic lymphocytic leukemiaHadas Lewinsky, Avital F Barak, Victoria Huber, et al.Haematologica|January 13, 2018
Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogoninClaudia Dürr, Bola S Hanna, Angela Schulz, et al.Haematologica|June 22, 2023
Interleukin-27 potentiates CD8+ T-cell-mediated antitumor immunity in chronic lymphocytic leukemiaGiulia Pagano, Iria Fernandez Botana, Marina Wierz, et al.Leukemia|February 2, 2021
EOMES and IL-10 regulate antitumor activity of T regulatory type 1 CD4<sup>+</sup> T cells in chronic lymphocytic leukemiaPhilipp M Roessner, Laura Llaó Cid, Ekaterina Lupar, et al.Blood|October 18, 2021
Evaluation of vecabrutinib as a model for noncovalent BTK/ITK inhibition for treatment of chronic lymphocytic leukemiaBilly Michael Chelliah Jebaraj, Annika Müller, Rashmi Priyadharshini Dheenadayalan, et al.International Journal of Cancer|November 24, 2018
Selective BTK inhibition improves bendamustine therapy response and normalizes immune effector functions in chronic lymphocytic leukemiaEriong Lee-Vergés, Bola S Hanna, Haniyeh Yazdanparast, et al.Pageof 7